Leonard J - Search Results

1

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Coleman M, et al. Among authors: leonard j. Semin Oncol. 2003 Apr;30(2):270-4. doi: 10.1053/sonc.2003.50044. Semin Oncol. 2003. PMID: 12720151 Clinical Trial.

2

Primary non-Hodgkin's lymphoma of bone.

Leonard JP, Coleman M. Leonard JP, et al. Cancer Invest. 1998;16(8):616-7. doi: 10.3109/07357909809032893. Cancer Invest. 1998. PMID: 9844623 No abstract available.

3

Treatment of nonlaparotomized (clinical) stage I and II Hodgkin's disease patients by extended field and splenic irradiation.

Coleman M, Kaufmann T, Nisce LZ, Leonard JP. Coleman M, et al. Among authors: leonard jp. Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1235-8. doi: 10.1016/s0360-3016(99)00511-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10725636

4

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).

Coleman M, Leonard J, Shuster MW, Kaufman TP. Coleman M, et al. Among authors: leonard j. Eur J Haematol Suppl. 2001 Jul;64:41-5. Eur J Haematol Suppl. 2001. PMID: 11486401 Clinical Trial.

5

Biology and management of mantle cell lymphoma.

Leonard JP, Schattner EJ, Coleman M. Leonard JP, et al. Curr Opin Oncol. 2001 Sep;13(5):342-7. doi: 10.1097/00001622-200109000-00005. Curr Opin Oncol. 2001. PMID: 11555710 Review.

6

Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).

Leonard JP, Link BK. Leonard JP, et al. Semin Oncol. 2002 Feb;29(1 Suppl 2):81-6. Semin Oncol. 2002. PMID: 11842393 Review.

7

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.

Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. Cancer. 2002 Feb 15;94(4):879-88. Cancer. 2002. PMID: 11920454 Free article. Clinical Trial.

8

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. J Nucl Med. 2002 Aug;43(8):1018-27. J Nucl Med. 2002. PMID: 12163626 Free article.

9

BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.

Coleman M, Leonard J, Lyons L, Pekle K, Nahum K, Pearse R, Niesvizky R, Michaeli J. Coleman M, et al. Among authors: leonard j. Leuk Lymphoma. 2002 Sep;43(9):1777-82. doi: 10.1080/1042819021000006303. Leuk Lymphoma. 2002. PMID: 12685831

10

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Leonard JP, et al. J Clin Oncol. 2003 Aug 15;21(16):3051-9. doi: 10.1200/JCO.2003.01.082. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837807 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,995 results

Search Page

Filters